N-cadherin levels were significantly (p < 0.001) elevated to 28.5 ± 2.54 ng/mL in the BLM-induced group compared to the sham group, whereas vincamine treatment notably (p < 0.001) decreased N-cadherin levels to 11.37 ± 1.43 ng/mL compared to the BLM-induced group (Figure 3B). The gene discussed is CDH2; the disease is Bloom syndrome.